Computer scientist, physicist, entrepreneur and investor whose work spans artificial intelligence and complex systems. He is the founder and managing partner of Reified.
Eli Lilly's GLP-1 franchise (Mounjaro, retatrutide) is driving it toward a trillion-dollar valuation, and the market is clearly signaling that longevity drugs and AI are the two obvious industries of the future.
Compute is becoming a financial commodity, but the massive capital expenditure required for AI infrastructure cannot scale efficiently without futures, options and other hedging instruments. Orin is building that missing market infrastructure.
Nonlinear path to 3.5T: merger gives SpaceX Optimus revenue (multi-trillion $/yr), hyperscaler services expand to orbital Dyson swarm (trillions), while Starlink and automotive become negligible. Core strength is physical infrastructure, not application layer.